MRCP and pancreatic cancer

NEW YORK, July 17 (Praxis Press) Magnetic resonance cholangiopancreatography (MRCP) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP), but its accuracy has not been proven in a large controlled study. Adamek and colleagues prospectively compared MRCP and ERCP for the differentiation of pancreatic lesions in 124 patients with suspected pancreatic cancer (see paper). For the diagnosis of pancreatic cancer, MRCP had a sensitivity of 84% and a specificity of 97%, wh

July 21, 2000

NEW YORK, July 17 (Praxis Press) Magnetic resonance cholangiopancreatography (MRCP) is a promising alternative to endoscopic retrograde cholangiopancreatography (ERCP), but its accuracy has not been proven in a large controlled study. Adamek and colleagues prospectively compared MRCP and ERCP for the differentiation of pancreatic lesions in 124 patients with suspected pancreatic cancer (see paper). For the diagnosis of pancreatic cancer, MRCP had a sensitivity of 84% and a specificity of 97%, whereas ERCP had a sensitivity of 70% and a specificity of 94%. MRCP is at least as sensitive as ERCP for the detection of pancreatic cancer and may prevent unnecessary exploratory procedures.

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham